{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T00:48:35Z","timestamp":1794012515869,"version":"4.8.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T00:00:00Z","timestamp":1595980800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["FI17\/00233"],"award-info":[{"award-number":["FI17\/00233"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK119431"],"award-info":[{"award-number":["DK119431"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19\/01710"],"award-info":[{"award-number":["PI19\/01710"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI16\/01321"],"award-info":[{"award-number":["PI16\/01321"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.ekir.2020.07.028","type":"journal-article","created":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T12:18:25Z","timestamp":1596284305000},"page":"1764-1776","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["A Comprehensive Phenotypic and Functional Immune Analysis Unravels Circulating Anti\u2013Phospholipase A2 Receptor Antibody Secreting Cells in Membranous Nephropathy Patients"],"prefix":"10.1016","volume":"5","author":[{"given":"Chiara","family":"Cantarelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Jarque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Angeletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquin","family":"Manrique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Hartzell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"O\u2019Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliot","family":"Merritt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uri","family":"Laserson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Perin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Donadei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Fischman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Draibe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Fulladosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Torras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo V.","family":"Riella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"La Manna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Fiaccadori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Maggiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriol","family":"Bestard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Cravedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2020.07.028_bib1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1053\/j.ajkd.2010.01.008","article-title":"The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey","volume":"56","author":"Glassock","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2020.07.028_bib2","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3181\/00379727-100-24736","article-title":"Production of nephrotic syndrome in rats by Freund's adjuvants and rat kidney suspensions","volume":"100","author":"Heymann","year":"1959","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.ekir.2020.07.028_bib3","first-page":"1324804","article-title":"Anti-PLA2R1 antibodies containing sera induce in\u00a0vitro cytotoxicity mediated by complement activation","volume":"2019","author":"Lateb","year":"2019","journal-title":"J\u00a0Immunol Res"},{"key":"10.1016\/j.ekir.2020.07.028_bib4","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ekir.2020.01.018","article-title":"Proteomic analysis of complement proteins in membranous nephropathy","volume":"5","author":"Ravindran","year":"2020","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ekir.2020.07.028_bib5","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ekir.2020.02.1033","article-title":"Complement pathways in membranous nephropathy: complex and multifactorial","volume":"5","author":"Brglez","year":"2020","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ekir.2020.07.028_bib6","doi-asserted-by":"crossref","first-page":"18091809","DOI":"10.3389\/fimmu.2019.01809","article-title":"Immunological pathogenesis of membranous nephropathy: focus on PLA2R1 and its role","volume":"10","author":"Liu","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.ekir.2020.07.028_bib7","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.semnephrol.2013.08.004","article-title":"The role of complement in membranous nephropathy","volume":"33","author":"Ma","year":"2013","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.ekir.2020.07.028_bib8","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0025-6196(26)04818-4","article-title":"The clinical course of idiopathic membranous nephropathy","volume":"48","author":"Erwin","year":"1973","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ekir.2020.07.028_bib9","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12882-017-0525-6","article-title":"Factors affecting the long-term outcomes of idiopathic membranous nephropathy","volume":"18","author":"Huh","year":"2017","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.ekir.2020.07.028_bib10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJM199307083290203","article-title":"Prognosis of untreated patients with idiopathic membranous nephropathy","volume":"329","author":"Schieppati","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2020.07.028_bib11","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/phar.1575","article-title":"Overview of current and alternative therapies for idiopathic membranous nephropathy","volume":"35","author":"Tran","year":"2015","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ekir.2020.07.028_bib12","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.kint.2018.10.021","article-title":"Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies","volume":"95","author":"Bobart","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2020.07.028_bib13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2020.07.028_bib14","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/ki.2012.486","article-title":"Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy","volume":"83","author":"Kanigicherla","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2020.07.028_bib15","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1681\/ASN.2017070734","article-title":"Phospholipase A2 receptor 1 epitope spreading at baseline predicts reduced likelihood of remission of membranous nephropathy","volume":"29","author":"Seitz-Polski","year":"2018","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2020.07.028_bib16","first-page":"75","article-title":"Two-color analysis of lymphocyte subpopulations in patients with nephrotic syndrome due to membranous nephropathy","volume":"38","author":"Ozaki","year":"1992","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.ekir.2020.07.028_bib17","first-page":"86","article-title":"Correlation between B lymphocyte abnormality and disease activity in patients with idiopathic membranous nephropathy","volume":"39","author":"Wang","year":"2011","journal-title":"J\u00a0Int Med Res"},{"key":"10.1016\/j.ekir.2020.07.028_bib18","first-page":"70","article-title":"T\u00a0cell subset\u00a0alterations in idiopathic glomerulonephritis","volume":"50","author":"Cagnoli","year":"1982","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ekir.2020.07.028_bib19","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.kint.2017.01.012","article-title":"B- and T-cell subpopulations in patients with severe idiopathic membranous nephropathy may predict an early response to rituximab","volume":"92","author":"Rosenzwajg","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2020.07.028_bib20","doi-asserted-by":"crossref","first-page":"R108","DOI":"10.1186\/ar3042","article-title":"Decreased frequency and activated phenotype of blood CD27 IgD IgM B lymphocytes is a permanent abnormality in systemic lupus erythematosus patients","volume":"12","author":"Rodriguez\u2013Bayona","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ekir.2020.07.028_bib21","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/cei.12703","article-title":"A\u00a0comprehensive investigation on the distribution of circulating follicular T helper cells and B cell subsets in primary Sjogren's syndrome and systemic lupus erythematosus","volume":"183","author":"Szabo","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ekir.2020.07.028_bib22","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/kisup.2012.20","article-title":"Chapter 7: idiopathic membranous nephropathy","volume":"2","year":"2012","journal-title":"Kidney Int Suppl (2011)"},{"key":"10.1016\/j.ekir.2020.07.028_bib23","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/tri.13014","article-title":"Refinement of humoral immune monitoring in kidney transplantation: the role of \"hidden\" alloreactive memory B cells","volume":"30","author":"Luque","year":"2017","journal-title":"Transpl Int"},{"key":"10.1016\/j.ekir.2020.07.028_bib24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jim.2018.07.011","article-title":"A\u00a0multicolour HLA-specific B-cell FluoroSpot assay to functionally track circulating HLA-specific memory B cells","volume":"462","author":"Luque","year":"2018","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.ekir.2020.07.028_bib25","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/ajt.15055","article-title":"Value of monitoring circulating donor-reactive memory B cells to characterize antibody-mediated rejection after kidney transplantation","volume":"19","author":"Luque","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2020.07.028_bib26","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nbt.1856","article-title":"Autoantigen discovery with a synthetic human peptidome","volume":"29","author":"Larman","year":"2011","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.ekir.2020.07.028_bib27","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1038\/s41596-018-0025-6","article-title":"PhIP-Seq characterization of serum antibodies using oligonucleotide-encoded peptidomes","volume":"13","author":"Mohan","year":"2018","journal-title":"Nat Protoc"},{"key":"10.1016\/j.ekir.2020.07.028_bib28","doi-asserted-by":"crossref","first-page":"E7526","DOI":"10.1073\/pnas.1615990113","article-title":"Systematic autoantigen analysis identifies a distinct subtype of scleroderma with coincident cancer","volume":"113","author":"Xu","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ekir.2020.07.028_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaa0698","article-title":"Viral immunology. Comprehensive serological profiling of human populations using a synthetic human virome","volume":"348","author":"Xu","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ekir.2020.07.028_bib30","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2307\/2532694","article-title":"Adjusted P-values for simultaneous inference","volume":"48","author":"Wright","year":"1992","journal-title":"Biometrics"},{"key":"10.1016\/j.ekir.2020.07.028_bib31","series-title":"An Introduction to Statistical Learning","author":"James G WD","year":"2013"},{"key":"10.1016\/j.ekir.2020.07.028_bib32","series-title":"Stata 16 Base Reference Manual","year":"2019"},{"key":"10.1016\/j.ekir.2020.07.028_bib33","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1681\/ASN.2010090967","article-title":"Anti-phospholipase A2 receptor antibody in membranous nephropathy","volume":"22","author":"Qin","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2020.07.028_bib34","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.4049\/jimmunol.171.4.1684","article-title":"Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals","volume":"171","author":"Cassese","year":"2003","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ekir.2020.07.028_bib35","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1681\/ASN.2014070640","article-title":"Anti-phospholipase A2 receptor antibody titer predicts post-rituximab outcome of membranous nephropathy","volume":"26","author":"Ruggenenti","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2020.07.028_bib36","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa1814427","article-title":"Rituximab or cyclosporine in the treatment of membranous nephropathy","volume":"381","author":"Fervenza","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2020.07.028_bib37","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.2215\/CJN.01730408","article-title":"Effects of rituximab on morphofunctional abnormalities of membranous glomerulopathy","volume":"3","author":"Ruggenenti","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2020.07.028_bib38","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1002\/art.11181","article-title":"Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis","volume":"48","author":"Cambridge","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ekir.2020.07.028_bib39","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ncpneph0133","article-title":"Drug insight: rituximab in renal disease and transplantation","volume":"2","author":"Salama","year":"2006","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1016\/j.ekir.2020.07.028_bib40","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1517\/14656566.8.18.3159","article-title":"Latest treatment strategies for membranous nephropathy","volume":"8","author":"Ruggenenti","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ekir.2020.07.028_bib41","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000368589","article-title":"Rituximab in primary membranous nephropathy: first-line therapy, why not?","volume":"128","author":"Cravedi","year":"2014","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.ekir.2020.07.028_bib42","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1191\/0961203304lu1014oa","article-title":"Correlation of circulating CD27high plasma cells and disease activity in systemic lupus erythematosus","volume":"13","author":"D\u00f6rner","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.ekir.2020.07.028_bib43","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1365-2362.1994.tb02022.x","article-title":"Increase of tumour necrosis factor alpha synthesis and gene expression in peripheral blood mononuclear cells of children with idiopathic nephrotic syndrome","volume":"24","author":"Bustos","year":"1994","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ekir.2020.07.028_bib44","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3346\/jkms.1997.12.6.539","article-title":"Circulating factors in sera or peripheral blood mononuclear cells in patients with membranous nephropathy or diabetic nephropathy","volume":"12","author":"Ihm","year":"1997","journal-title":"J\u00a0Korean Med Sci"},{"key":"10.1016\/j.ekir.2020.07.028_bib45","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0272-6386(12)80742-6","article-title":"Elevated levels of tumor necrosis factor-alpha in the nephrotic syndrome in humans","volume":"21","author":"Suranyi","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2020.07.028_bib46","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/sj.ki.5002054","article-title":"TNFA2 and d2 alleles of the tumor necrosis factor alpha gene polymorphism are associated with onset\/occurrence of idiopathic membranous nephropathy","volume":"71","author":"Thibaudin","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2020.07.028_bib47","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/jlb.61.6.667","article-title":"Expression of TNF-\u03b1 by human plasma cells in chronic inflammation","volume":"61","author":"Di Girolamo","year":"1997","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.ekir.2020.07.028_bib48","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1084\/jem.168.5.1539","article-title":"Production of tumor necrosis factor\/cachectin by human B cell lines and tonsillar B cells","volume":"168","author":"Sung","year":"1988","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.ekir.2020.07.028_bib49","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa051907","article-title":"Messenger RNA for FOXP3 in the urine of renal-allograft recipients","volume":"353","author":"Muthukumar","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2020.07.028_bib50","first-page":"328","article-title":"CD20-positive infiltrates in human membranous glomerulonephritis","volume":"18","author":"Cohen","year":"2005","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.ekir.2020.07.028_bib51","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nri.2015.1","article-title":"Regulatory T cell memory","volume":"16","author":"Rosenblum","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ekir.2020.07.028_bib52","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1002\/eji.200526065","article-title":"Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis","volume":"35","author":"Haas","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.ekir.2020.07.028_bib53","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.4049\/jimmunol.1003224","article-title":"CD4+FOXP3+ T regulatory cells in human autoimmunity: more than a numbers game","volume":"187","author":"Long","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ekir.2020.07.028_bib54","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3389\/fmed.2019.00241","article-title":"Immune-monitoring disease activity in primary membranous nephropathy","volume":"6","author":"Cravedi","year":"2019","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ekir.2020.07.028_bib55","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2215\/CJN.11791018","article-title":"High-dose rituximab and early remission in PLA2R1-related membranous nephropathy","volume":"14","author":"Seitz-Polski","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2020.07.028_bib56","first-page":"103","article-title":"Bortezomib therapy for nephrotic syndrome due to idiopathic membranous nephropathy","volume":"27","author":"Hartono","year":"2014","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.ekir.2020.07.028_bib57","first-page":"350","article-title":"Bortezomib as a novel approach to early recurrent membranous glomerulonephritis after kidney transplant refractory to combined conventional rituximab therapy","volume":"15","author":"Barbari","year":"2017","journal-title":"Exp Clin Transplant"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024920314273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024920314273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:46:09Z","timestamp":1778892369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024920314273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":57,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S2468024920314273"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2020.07.028","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Comprehensive Phenotypic and Functional Immune Analysis Unravels Circulating Anti\u2013Phospholipase A2 Receptor Antibody Secreting Cells in Membranous Nephropathy Patients","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2020.07.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}